Change in weight (kg) · adults with disease‐related malnutrition
1 finding from 1 review
Change in fat‐free mass (kg) · adults with disease‐related malnutrition
1 finding from 1 review
QoL · adults with disease‐related malnutrition
1 finding from 1 review
All‐cause mortality · adults with disease‐related malnutrition
Dietary advice plus supplements showed no clear difference in mortality compared with no dietary advice plus no supplements (low certainty).
1 finding from 1 review
Length of hospital stay · adults with disease‐related malnutrition
1 finding from 1 review
Number of people admitted or re‐admitted to hospital · adults with disease‐related malnutrition
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Length of hospital stay · adults with disease‐related malnutrition
1 finding from 1 review
Complications · adults with disease‐related malnutrition
Dietary advice plus supplements may leads to lower complications compared with no dietary advice plus no supplements (low certainty).
1 finding from 1 review
Change in weight (kg) · adults with disease‐related malnutrition
1 finding from 1 review
Change in fat‐free mass (kg) · adults with disease‐related malnutrition
1 finding from 1 review
QoL · adults with disease‐related malnutrition
1 finding from 1 review
Complications · adults with disease‐related malnutrition
1 finding from 1 review
Change in weight (kg) · adults with disease‐related malnutrition
1 finding from 1 review
Change in fat‐free mass (kg) · adults with disease‐related malnutrition
1 finding from 1 review
QoL · adults with disease‐related malnutrition
1 finding from 1 review
Outcome: · ambulatory people with cancer without venous thromboembolism receiving systemic therapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality at 6 months: main analysis · ambulatory people with cancer without venous thromboembolism receiving systemic therapy
Vitamin K antagonist (VKA) prophylaxis showed no clear difference in mortality at 6 months: main analysis compared with no prophylaxis (moderate certainty).
1 finding from 1 review
All‐cause mortality · ambulatory people with cancer without venous thromboembolism receiving systemic therapy
Vitamin K antagonist (VKA) prophylaxis showed no clear difference in mortality compared with no prophylaxis (moderate certainty).
1 finding from 1 review
Pulmonary embolism · ambulatory people with cancer without venous thromboembolism receiving systemic therapy
It is very uncertain whether vitamin K antagonist (VKA) prophylaxis changes pulmonary embolism compared with no prophylaxis (very low certainty).
1 finding from 1 review
Symptomatic DVT · ambulatory people with cancer without venous thromboembolism receiving systemic therapy
It is very uncertain whether vitamin K antagonist (VKA) prophylaxis changes symptomatic deep vein thrombosis compared with no prophylaxis (very low certainty).
1 finding from 1 review